Oric Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$11.73

+0.03 (+0.26%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 19 90%

Hold 2 10%

Sell 0 0%

Price Target

Analyst Price Target +345.5% upside

Low Target $31.55

Average Target $52.26

High Target $71.26

Current Price $11.73

Current
$11.73

Target
$52.26

$31.55 $52.26 avg $71.26

Scenario Analysis

Bear Case

$31.55

169.0%

Low target

Base Case

$52.26

+345.5%

Avg target

Bull Case

$71.26

+507.5%

High target

Risk/Reward

3.0x

Highly favorable

Price in Context

52-Week High

$14.93

-21.4% from high

52-Week Low

$3.90

+201.1% from low

Target vs 52W High

$52.26

+250.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%